Asia-Pacific Journal of Clinical Oncology

Article	Citations
Role and mechanism of autophagy‐regulating factors in tumorigenesis and drug resistance	63
An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic	46
Mechanisms of long non‐coding RNA function in colorectal cancer tumorigenesis	32
Mainstream consent programs for genetic counseling in cancer patients: A systematic review	29
COVID‐19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: A multicenter study	22
Neurological immune‐related adverse events associated with immune checkpoint inhibitors: A review of the literature	21
Image‐guided percutaneous microwave ablation of early‐stage non–small cell lung cancer	21
Measuring financial toxicity in Australian cancer patients – Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients	19
Young‐onset colorectal cancer is associated with a personal history of type 2 diabetes	18
Is temporal muscle thickness a survival predictor in newly diagnosed glioblastoma multiforme?	15
LINC01133 promotes the progression of cervical cancer via regulating miR‐30a‐5p/FOXD1	15
Rheumatic immune‐related adverse events induced by immune checkpoint inhibitors	14
Updates to the drug‐resistant mechanism of proteasome inhibitors in multiple myeloma	14
Exosomal miR‐21/Let‐7a ratio distinguishes non‐small cell lung cancer from benign pulmonary diseases	14
Roles of Myc‐associated zinc finger protein in malignant tumors	13
Real‐world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center	13
Overview of epidemiological characteristics, clinical features, and risk factors of gastric cancer in Asia‐Pacific region	13
A systematic review of the barriers to implementing human papillomavirus vaccination programs in low‐ and middle‐income countries in the Asia‐Pacific	12
Financial toxicity in patients with cancer attending a public Australian tertiary hospital: A pilot study	12
Identifying ultrasound features of positive expression of Ki67 and P53 in breast cancer using radiomics	12
The changing paradigm of managing Merkel cell carcinoma in Australia: An expert commentary	12
Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease	12
Impact of COVID‐19 on cancer patients: A review	11
The adverse events associated with combination immunotherapy in cancers: Challenges and chances	11
Validity and reliability of the MD Anderson dysphagia inventory in English and Chinese in head and neck cancer patients	11

Short‐term multimodal prehabilitation improves functional capacity for colorectal cancer patients prior to surgery	10
USP21 upregulation in cholangiocarcinoma promotes cell proliferation and migration in a deubiquitinase‐dependent manner	10
Metabolic profiling analysis for clinical urine of colorectal cancer	10
Measurement, outcomes and interventions of cognitive function after breast cancer treatment: A narrative review	10
Factors associated with fear of cancer recurrence in breast and colorectal cancer survivors: A cross‐sectional study of cancer survivors	10
CDK4/6 inhibitor plus endocrine therapy for hormone receptor‐positive, HER2‐negative metastatic breast cancer: The new standard of care	9
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 in T cells from patients with non‐Hodgkin lymphoma	9
Tripartite motif‐containing 54 promotes gastric cancer progression by upregulating K63‐linked ubiquitination of filamin C	9
Age‐based efficacy and safety of nivolumab for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter retrospective study	9
Programmed cell death 1 (PD‐1)/PD‐ligand 1(PD‐L1) inhibitors‐related pneumonitis in patients with advanced non–small cell lung cancer	8
Clinicopathological features and prognosis of patients with pregnancy‐associated breast cancer: A matched case control study	8
Enkurin domain containing 1 (ENKD1) regulates the proliferation, migration and invasion of non‐small cell lung cancer cells	8
Metabolic behavior and prognostic role of pretreatment 18F‐FDG PET/CT in gist	8
Clinical factors for predicting malignancy in patients with PSA < 10 ng/mL and PI‐RADS 3 lesions	8
Nomogram based on the systemic immune‐inflammation index for predicting the prognosis of diffuse large B‐cell lymphoma	8
Screening and surveillance for gastric cancer: Does family history play an important role in shaping our strategy?	8
Poster Abstracts	8
Advances and challenges of neoadjuvant therapy in pancreatic cancer	8
Drug induced vitiligo‐like depigmentation from a CDK 4/6 inhibitor	8
The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer	8
R‐CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B‐cell lymphoma	7
Retrospective analysis of hospital admissions due to immune checkpoint inhibitor‐induced immune‐related adverse events (irAE)	7
Understanding mammographic breast density profile in China: A Sino‐Australian comparative study of breast density using real‐world data from cancer screening programs	7
Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries	7
Serum level of interleukin‐35 as a potential prognostic factor for gastric cancer	7
Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation	7
Increased rates of cetuximab reactions in tick prevalent regions and a proposed protocol for risk mitigation	7
Recommendations to improve the clinical adoption of NGS‐based cancer diagnostics in Singapore	7
Long‐term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open‐label extension study	7
Overexpression of LINC00852 promotes prostate cancer cell proliferation and metastasis	7
Recommended testing algorithms for NTRK gene fusions in pediatric and selected adult cancers: Consensus of a Singapore Task Force	7
The survival benefit of radiotherapy in localized primary adult rhabdomyosarcoma	7
Immune checkpoint inhibitor‐related cutaneous adverse events	7
miRNA‐31 increases radiosensitivity through targeting STK40 in colorectal cancer cells	7
Prostate cancer management in the era of COVID‐19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro‐oncology	6
Randomized study comparing mannitol with furosemide for the prevention of cisplatin‐induced renal toxicity in non‐small cell lung cancer: The OLCSG1406 trial	6
Awareness of and preference for disease prognosis and participation in treatment decisions among advanced cancer patients in Myanmar: Results from the APPROACH study	6
Prevention of docetaxel‐associated febrile neutropenia with primary granulocyte colony‐stimulating factor in Chinese metastatic hormone‐sensitive and castration‐resistant prostate cancer patients	6
Gastrostomy dependency trends over 15 years of patients at a large tertiary referral center following the insertion of a prophylactic gastrostomy for chemoradiation for mucosal head and neck cancer	6
The management of HER2‐positive early breast cancer: Current and future therapies	6
Dynamic changes in systemic immune‐inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemot	6
The pathophysiology and current treatments for the subcutaneous panniculitis‐like T cell lymphoma: An updated review	6
TYK2 is a prognostic biomarker and associated with immune infiltration in the lung adenocarcinoma microenvironment	6
The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer	6
Renal immune‐related adverse events of immune checkpoint inhibitor	6
Value of 3Tesla MRI in the preoperative staging of mid‐low rectal cancer and its impact on clinical strategies	6
Association between financial toxicity and health‐related quality of life in cancer survivors: A systematic review	6
Breast cancer treatment‐related arm lymphoedema and morbidity: A 6‐year experience in an Australian tertiary breast centre	6
Conventional supportive cancer care services in Australia: A national service mapping study (The CIA study)	6
Lung cancer treatment patterns and factors relating to systemic therapy use in Australia	5

Opinions and strategies of Australian health professionals on tackling cancer‐related financial toxicity: A nationwide survey	5
The role of postoperative radiotherapy after primary tumor resection in patients with de novo stage IV breast cancer	5
Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort study	5
Combination chemotherapy with NAB®‐paclitaxel and capecitabine for patients with advanced biliary tract cancer (NAP‐CAPABIL Pilot Study)	5
Hsa‐miR‐27a‐3p and epidermal growth factor receptor expression analysis in glioblastoma FFPE samples	5
Poster Abstracts	5
Treatment outcomes for patients with metastatic castrate‐resistant prostate cancer following docetaxel for hormone‐sensitive disease	5
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis	5
Evaluating the predictive factors for anastomotic leakage after total laparoscopic resection with transrectal natural orifice specimen extraction for colorectal cancer	5
Phagocytosis checkpoints on hematopoietic stem cells in patients with myelodysplastic syndromes	5
Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia	5
Drug‐eluting bead transarterial chemoembolization with medium‐sized versus small‐sized CalliSpheres microspheres in unresectable primary liver cancer	5
Cyclophosphamide‐induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less	5
A consensus statement on the use of biosimilar medicines in hematology in Australia	5
Oral mucositis among Chinese cancer patients receiving chemotherapy: Effects and management strategies	5
Australia and New Zealand's responsibilities in improving oncology services in the Asia‐Pacific: A call to action	5
Expression of CD73 is associated with tumor progression and intratumoral inflammation in breast cancer	5
Programmed death ligand‐1 expression levels, clinicopathologic features, and survival in surgically resected sarcomatoid lung carcinoma	5
A national survey of oncology physiotherapy services for cancer survivors in Australia	5
Changes in DNA methylation after 6‐week exercise training in colorectal cancer survivors: A preliminary study	5
Preoperative docetaxel, cisplatin, and fluorouracil treatment with pegfilgrastim on day 7 for patients with esophageal cancer: A phase II study	5
The incidence and patterns of gastric cancers in Sri Lanka from 2001 to 2012: Analysis of National Cancer Registry Data	4
Low‐frequency ultrasound combined with microbubbles improves gene transfection in prostate cancer cells in vitro and in vivo	4
Experiences and perspectives of cancer stakeholders regarding COVID‐19 vaccination	4
Performance status as prognostic factor in phase III trials of first‐line chemotherapy of unresectable or metastatic pancreatic cancer: A trial‐level meta‐analysis	4
Efficacy of abiraterone acetate in castration‐resistant metastatic prostate cancer: A real‐world data analysis	4
Long‐term survival and prognostic analysis of advanced stage follicular lymphoma in the rituximab era: A China single‐center retrospective study	4
Current status and temporal trend of disease burden of thyroid cancer in China from 1990 to 2019	4
Reliability and validity of the Cancer Health Literacy Test – Chinese versions: CHLT‐30‐Chinese and CHLT‐6‐Chinese	4
Long‐term clinical outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy using the CyberKnife® robotic radiosurgery system for vestibular schwannoma	4
Strategies for patient with cancer during COVID‐19 pandemic	4
Loss of adipose tissue or skeletal muscle during first‐line gemcitabine/nab‐paclitaxel therapy is associated with worse survival after second‐line therapy of advanced pancreatic cancer	4
Molecular basis and targeted therapies for radioiodine refractory thyroid cancer	4
Efficacy of cabazitaxel and the influence of clinical factors on the overall survival of patients with castration‐resistant prostate cancer: A local experience of a multicenter retrospective study	4
Clinical trials knowledge and attitudes of Vietnamese‐ and Anglo‐Australian cancer patients: A cross‐sectional study	4
Radiation oncology during COVID‐19: Strategies to avoid compromised care	4
Managing advanced prostate cancer in the Asia Pacific region: “Real‐world” application of Advanced Prostate Cancer Consensus Conference 2019 statements	4
End of life experiences of patients with advanced cancer in Myanmar: Results from the APPROACH study	4
Distribution of tumor subtypes in bilateral breast cancer: Comparison between synchronous and metachronous cancer	4
Oxycodone/naloxone prolonged‐release tablets in patients with moderate‐to‐severe, chronic cancer pain: Challenges in the context of hepatic impairment	4
Sentinel lymph node biopsy in acral melanoma: A Korean single‐center experience with 107 patients (2006–2018)	4
Early administration of durvalumab after chemoradiotherapy increased risk of pneumonitis in patients with locally advanced non‐small cell lung cancer	4
The role of combining immunotherapy with primary (Chemo)radiotherapy in curative treatment settings of the head and neck cancer	4
Telehealth adoption in cancer clinical trials: An Australian perspective	4
Teletrials, the new norm? Expert recommendations for teletrials into the future: Findings from the Clinical Oncology Society of Australia Clinical Trial Research Professionals Group Workshop	4
Prevention and management of acneiform rash associated with EGFR inhibitor therapy: A systematic review and meta‐analysis	4
Tamoxifen use in recurrent ovarian cancer in a Chinese population: A 15 ‐year clinical experience in a tertiary referral center	4
Risk of nasopharyngeal carcinoma in patients with chronic rhinosinusitis: A nationwide propensity score matched study in Taiwan	4
Estimation of malignancy of pulmonary nodules at CT scans: Effect of computer‐aided diagnosis on diagnostic performance of radiologists	4
Real‐world impact of anti‐HER2 therapy‐related cardiotoxicity in patients with advanced HER2‐positive breast cancer	4
Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosis	4
Radiotherapy service need in the Pacific Island countries	4
RPRD1B is a potentially molecular target for diagnosis and prevention of human papillomavirus E6/E7 infection‐induced cervical cancer: A case‐control study	4
Accurate prediction of epidermal growth factor receptor mutation status in early‐stage lung adenocarcinoma, using radiomics and clinical features	4
The venous thromboembolism prophylaxis in patients receiving thoracic surgery: A systematic review	4
Current status and future perspectives on immunotherapy in neoadjuvant therapy of resectable non‐small cell lung cancer	4
Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer	4
Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer	4
Treatment and toxic effects of prophylactic cranial irradiation in stage II–III non–small cell lung cancer: A meta‐analysis	4
Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001‐2015	4
Implementation and evaluation of a smoking cessation checklist implemented within Australian cancer services	4
miR‐425 regulates ovarian cancer proliferation, metastasis, and apoptosis by repressing PAK4 expression	4
Opportunities and barriers for the use of Australian cancer registries as platforms for randomized clinical trials	4
Genetic aberrations involved in relapse of pediatric acute myeloid leukemia: A literature review	4
Advances in immune neoadjuvant/adjuvant therapy‐related adverse events of non‐small cell lung cancer	4
Oral Abstracts	3
Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta‐analysis	3
Efficacy, toxicity, and quality‐of‐life outcomes of ultrahypofractionated radiotherapy in patients with localized prostate cancer: A single‐arm phase 2 trial from Asia	3
Incidence and appropriate management of drug‐induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study	3
	3
MR‐guided simulation is superior than FDG/PET‐guided simulation for local control in nasopharyngeal cancer patients treated with intensity‐modulated radiotherapy	3
The clinical features, treatment, and prognostic factors for peripheral T‐cell lymphomas: A single‐institution analysis of 240 Chinese patients	3
Radium‐223 in Asian patients with castration‐resistant prostate cancer with symptomatic bone metastases: A single‐arm phase 3 study	3
Molecular characteristics of young‐onset colorectal cancer in Vietnamese patients	3
The therapeutic effects of berberine for gastrointestinal cancers	3
Olaparib maintenance monotherapy in Chinese patients with platinum‐sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial	3
Barriers and potential solutions to international collaboration in neuro‐oncology clinical trials: Challenges from the Australian perspective	3
Current status of PSMA PET imaging in prostate cancer	3
Dilemma and solutions of treatment delay in cancer patients during the COVID‐19 pandemic: A single‐center, prospective survey	3
Percutaneous endobiliary radiofrequency ablation and stents in management of hepatocellular carcinoma with bile duct tumor thrombus: Initial single‐institution experience	3

Different patterns of treatment‐related adverse events of programmed cell death‐1 and its ligand‐1 inhibitors in different cancer types: A meta‐analysis and systemic review of clinical trials	3
	3
Combinatorial approach of immuno‐proton therapy in cancer: Rationale and potential impact	3
Psoas muscle depletion during preoperative chemotherapy for advanced gastric cancer has a negative impact on long‐term outcomes after gastrectomy	3
Comparison between flattening filter‐free (FFF) and flattened photon beam VMAT plans for the whole brain radiotherapy (WBRT) with hippocampus sparing	3
Optimizing care for younger women with hormone receptor‐positive, HER2‐negative metastatic breast cancer	3
Prognostic analysis for children with hepatoblastoma with lung metastasis: A single‐center analysis of 98 cases	3
Disulfiram‐copper activates chloride currents and induces apoptosis with tyrosine kinase in prostate cancer cells	3
Dismal outcome of relapsed or primary refractory adult T‐cell lymphoblastic lymphoma: A retrospective study from China	3
MDM4 polymorphisms associated with the risk but not the prognosis of esophageal cancer in Cixian high‐incidence region from northern China	3
High‐dose methotrexate monotherapy for newly diagnosed primary central nervous system lymphoma: 15‐year multicenter experience	3
3D‐T2W‐TSE radiotherapy treatment planning MRI using compressed sensing acceleration for prostate cancer: Image quality and delineation value	3
Postoperative radiotherapy improves overall survival in patients with primary squamous cell carcinoma of the breast	3
Clinical evidence and insights supporting the use of avelumab first‐line maintenance treatment in patients with advanced urothelial carcinoma in the Asia‐Pacific region	3
Role of stereotactic body radiotherapy for early‐stage non‐small‐cell lung cancer in patients borderline for surgery due to impaired pulmonary function	3
Olaparib dose re‐escalation in ovarian cancer patients who experienced severe and/or uncommon adverse events: A case series	3
Patient demographics and management landscape of metastatic colorectal cancer in the third‐line setting: Real‐world data in an australian population	3
Lower tumor volume is associated with increased benefit from immune checkpoint inhibitors in patients with advanced non‐small‐cell lung cancer	3
Resilience and ongoing quality care for cancer clinical trials during COVID‐19: Experience from a tertiary hospital in Australia	3
Clinical characterization of glioblastoma patients living longer than 2 years: A retrospective analysis of two Italian institutions	3
The prognostic value of aspartate aminotransferase‐to‐lymphocyte ratio index in early‐stage hepatocellular carcinoma after hepatectomy: A propensity‐score matched analysis	3
Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT+ NK cells may be related to poor outcome in acute myeloid leukemia	3
	3
Bladder filling volume variation between the first and second day of planning computed tomography for prostate cancer radiation therapy and correlation with renal function	3
Perioperative versus postoperative chemotherapy for gastric cancer: A propensity score matched analysis	3
Carboplatin and hypomagnesemia: Is it really a problem?	3
Immune checkpoint inhibitor therapy for cancer patients infected with HIV: A systematic review	3
Do histopathological features of breast cancer in Australian Indigenous women explain the survival disparity? A two decade long study in the Northern Territory	3
v‐myb avian myeloblastosis viral oncogene homolog expression is a potential molecular diagnostic marker for B‐cell acute lymphoblastic leukemia	3
Referral and uptake of services by distressed callers to the Cancer Council Information and Support telephone service	3
The national trend of the gastric cancer burden in Iran from 1990 to 2017	3
A prospective phase II study of raltitrexed combined with S‐1 as salvage treatment for patients with refractory metastatic colorectal cancer	3
Prognostic performance of qSOFA in oncology patients admitted to the emergency department with suspected infection	3
Upregulation of O‐GlcNAc transferase is involved in the pathogenesis of acute myeloid leukemia	3
A phase I study of LCL161, a novel oral pan‐inhibitor of apoptosis protein (IAP) antagonist, in Japanese patients with advanced solid tumors	3
Longitudinal study of intravenous versus subcutaneous immunoglobulin replacement therapy in hematological malignancy	3
Early salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: Its impact and optimal candidate	3
Docetaxel and cisplatin induction chemotherapy with or without fluorouracil in locoregionally advanced nasopharyngeal carcinoma: A retrospective propensity score matching analysis	3
Current status of total neoadjuvant therapy for locally advanced rectal cancer	3
Physalin B inhibits cell proliferation and induces apoptosis in undifferentiated human gastric cancer HGC‐27 cells	3
Differences in lesion interpretation between radiologists in two countries: Lessons from a digital breast tomosynthesis training test set	3
The influence of transarterial chemoembolization on serum levels of soluble programed cell death ligand‐1 in advanced hepatocellular carcinoma patients	3
Production and characterization of haploidentical CD19 CAR T cells: Validated to induce a continuous complete remission in a patient with relapsed refractory B‐cell ALL	3